Background Hair follicle-derived mesenchymal stem cell (HF-MSC)-based therapies protect
against acute pancreatitis (AP). However, accumulating evidence suggests that MSC-based …

Acute pancreatitis (AP) may be associated with both local and systemic complications.
Although it is usually self-limiting, up to 20% of patients develop severe acute pancreatitis …

Acinar cell injury and the inflammatory response are critical bioprocesses of acute
pancreatitis (AP). We investigated the role and underlying mechanism of sulfiredoxin-1 …

Background and Purpose Macrophage infiltration and activation is a critical step during
acute pancreatitis (AP). We have shown that pancreas‐specific D2 receptor signalling …

Acute pancreatitis (AP) is an inflammatory disease of the pancreas. The severity is classified
as mild (MAP), moderately severe (MSAP), or severe (SAP). In patients with SAP, organ …

Acute pancreatitis (AP) is an acute inflammatory disease of the exocrine pancreas. The
pathogenesis of AP is still unclear, and there is currently no specific treatment. A variety of …

Acute pancreatitis (AP) is a common inflammatory disease of the digestive system.
Mitochondrial calcium uniporter (MCU) mediates mitochondrial uptake of Ca 2+ and plays …

Background Metabolic risk factors, such as obesity, hypertension, and hyperlipidemia are
independent risk factors for the development of various complications in acute pancreatitis …

Urolithin A (Uro A) is a dietary metabolite of the intestinal microbiota following the ingestion
of plant-based food ingredients ellagitannins and ellagic acid in mammals. Accumulating …

Severe acute pancreatitis (SAP), as a typical acute inflammatory injury disease, is one of the
acute gastrointestinal diseases with a remarkable mortality rate. Macrophages, typical …